Keurig Dr Pepper (NasdaqGS:KDP) Reports Sales Growth to US$15 Billion But Decline in Net Income in 2024

Simply Wall St.
26 Feb

Keurig Dr Pepper (NasdaqGS:KDP) saw its stock price rise by 9.53% over the last month, a notable movement in a period when broader markets experienced a 3% decline. This upward trend for Keurig Dr Pepper contrasts with the general downturn affecting major indices such as the S&P 500 and Nasdaq, which were impacted by declining tech stocks. Keurig Dr Pepper's performance followed its announcement of full-year earnings for 2024, which showed an increase in sales to USD 15,351 million from the previous year, despite a drop in net income to USD 1,441 million. In addition, the affirmation of a regular quarterly dividend of USD 0.23 per share may have strengthened investor confidence. While the wider market faced volatility amid investor concerns, these corporate events appeared to support positive sentiment and contributed to the price increase for KDP shares.

Unlock comprehensive insights into our analysis of Keurig Dr Pepper stock here.

NasdaqGS:KDP Earnings Per Share Growth as at Feb 2025

Over the last five years, Keurig Dr Pepper's total return, including share price movements and dividends, stood at 35.53%. This performance is reflective of several strategic decisions and market shifts that have shaped the company. The earnings milestones, such as the announcement on 2024-09-05 of the sales and distribution agreement with Black Rifle Coffee Company, have played a key role. Additionally, in 2024, Keurig Dr Pepper completed a follow-on equity offering amounting to US$1.97 billion, strengthening its financial position.

Further generating investor interest was the company’s decision on 2024-09-12 to increase its annualized dividend rate by 7% to US$0.92 per share. Besides, the strategic leadership changes in early 2025, which saw new appointments in vital roles, indicated a refreshed corporate direction. Meanwhile, the buyback of over 70 million shares since October 2021 underlines efforts to enhance shareholder value. Despite the challenges in the market, these factors have collectively supported the company's long-term return trajectory.

  • See how Keurig Dr Pepper measures up with our analysis of its intrinsic value versus market price.
  • Uncover the uncertainties that could impact Keurig Dr Pepper's future growth—read our risk evaluation here.
  • Is Keurig Dr Pepper part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Keurig Dr Pepper might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10